The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

DSpace Repository

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

Author: Hadji, Peyman; Stoetzer, Oliver; Decker, Thomas; Kurbacher, Christian M.; Marme, Frederik; Schneeweiss, Andreas; Mundhenke, Christoph; Distelrath, Andrea; Fasching, Peter A.; Lux, Michael P.; Lueftner, Diana; Janni, Wolfgang; Muth, Mathias; Kreuzeder, Julia; Quiering, Claudia; Grischke, Eva-Marie; Tesch, Hans
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Journal of Bone Oncology (2019), Bd. 14, Article UNSP 100199
Verlagsangabe: Elsevier Science Bv
Language: English
Full text: http://dx.doi.org/10.1016/j.jbo.2018.09.010
ISSN: 2212-1374
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)